UNIGE document Scientific Article - Review
previous document  unige:55145  next document
add to browser collection

Quelle surveillance médicale des adolescents sous antipsychotiques de deuxième génération ?

Published in Revue médicale suisse. 2014, vol. 10, no. 434, p. 1302,1304-7
Abstract Since the introduction of so called second generation antipsychotic (SGA), the prescription of these drugs has been relatively frequent in adolescence. This article gives a synopsis of the potential side effects and contra-indications, and proposes a practical guideline for the follow-up of these SGAs in adolescent and young adults. The main secondary side effects are in metabolic, endocrine, neurologic, cardiovascular systems and also on the hematological and liver functions. Thus, a strict follow-up should start before the introduction of a SGA treatment and should be continued during the time of administration. Since there is no common consent for a follow-up in SGA use in adolescents for Europe, this article may give a practical guideline for general practitioners and pediatricians, including a clinical exam and biological parameters to be controlled.
Keywords AdolescentAntipsychotic Agents/adverse effects/contraindications/therapeutic useAnxiety Disorders/drug therapyHumansHypertension/chemically inducedMaleProduct Surveillance, Postmarketing/methodsWeight Gain/drug effectsYoung Adult
PMID: 25073303
Full text
Research group Gastroentérologie et transplantation (pédiatrie) (181)
(ISO format)
HUBER-GIESEKE, Tina, PERIN MINISINI, Maria Iole, NARRING, Françoise. Quelle surveillance médicale des adolescents sous antipsychotiques de deuxième génération ?. In: Revue médicale suisse, 2014, vol. 10, n° 434, p. 1302,1304-7. https://archive-ouverte.unige.ch/unige:55145

155 hits



Deposited on : 2015-04-07

Export document
Format :
Citation style :